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Abstract 
We investigated the role of the 1st cytoplasmic loop of the thyrotropin receptor (TSHR) on signal transduction using mutants as we did the 2nd 
and 3rd cytoplasmic loops [Kosugi S. et al. (1994) Mol. Endocrinol., in press; and 7, 1009-10201. Five substitution mutants involving the first 
cytoplasmic loop showed a TSH- or Graves’ &G-stimulated CAMP response despite the low TSH binding B_. All the mutants completely lost or 
markedly decreased the TSH- or Graves’ IgG-stimulated inositol phosphate increase. These findings suggest that the 1st cytoplasmic loop of the TSHR 
does not play a crucial role in agonist-induced adenylate cyclase activation but that it is important for phosphoinositide signaling. 
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1. Introduction 2. Materials and methods 
The thyrotropin receptor (TSHR) activates phosphat- 
idylinositol bisphosphate (PIP,) as well as CAMP signals 
when stimulated by TSH or TSHR auto-antibodies from 
patients with Graves’ disease [la]. Both signals are in- 
volved in growth and various cellular function in thyroid 
cells [5]. Localization of sites in TSHR involved in each 
signal transduction is important for understanding the 
mechanism of receptor activation. We have investigated 
the 3rd [2,4] and 2nd [6] cytoplasmic loops of the TSHR 
by substituting the corresponding sequence from 
adrenergic receptors (ARs) and have found that: (i) the 
middle portion of the 2nd loop is important for agonist- 
induced CAMP production; (ii) widely distributed por- 
tions of the both loops are important for PIP* signaling; 
and (iii) both loops are important for regulating basal 
CAMP levels. 
2.1. Mutagenesis 
Oligonucleotide-mediated, site-directed mutagenesis was used to cre- 
ate the mutants as previously described [2,4,6]. 
2.2. Transfection 
Cos-7 cells were transfected with mutant DNA by electroporation 
12.4.61; 25 flu vurified nlasmid DNA was used in each. To evaluate the 
transfectidn~~ciency,~pSVGH wasco-transfected with mutant or wild- 
type (WT) TSHR or pSG5 vector cDNA. Aliquots of the same batch 
of transfected cells were plated for Northern blots, Western blots, TSH 
binding and cAMP/inositol phosphate assays. The medium was inositol 
free in the latter and supplemented with 2.5 #X/ml myo-[2-3H(N)]inos- 
itol (DuPont-NEN, Boston, MA). 
2.3. Assays 
To accomplish characterization of the roles of the cy- 
toplasmic loops in signal transduction activities, we have 
extended the substitution/mutagenesis tudy to the 1st 
cytoplasmic loop. 
All assays were simultaneously initiated 48 h after transfection [2,4,6] 
and after washing with assay buffer: NaCl-free, Hanks’ Balanced Salt 
Solution containing 0.5% BSA, 222 mM sucrose, and 20 mM HEPES 
at pH 7.4. [‘*‘I]TSH binding was measured after incubation for 2 h at 
22’C in 1 ml assay buffer containing [‘*‘I]TSH and 0 to lo-’ M unla- 
beled TSH. Specific binding was obtained by subtracting the values 
obtained in the presence of IO-’ M unlabeled TSH. Total CAMP and 
inositol phosphate levels were measured in the same wells after incuba- 
tion for 1 h at 37°C with 0.2 ml assay buffer containing 10 mM LiCl, 
0.5 mM 3-isobutyl-1-methylxanthine, and, as noted, 10-i’ to lo-’ M 
TSH, 0.5 or 5.0 mg/ml Graves’ or normal IgG, or 10 PM ATP. Total 
CAMP was measured by radioimmunoassay nd the inositol phosphate 
formation was determined using anion exchange columns. 
*Corresponding author. Fax: (81) (75) 751-3233 
All assays were performed in duplicate, on at least 3 sepa.rate occa- 
sions with different batches of cells, and with simultaneously run posi- 
tive and negative controls, namely cells transfected with WT TSHR or 
pSG5 vector alone respectively. Values in each well were corrected for 
amount of cell protein. The program LIGAND [7] and a single high 
affinity site model were used to calculate the Kd values for TSH binding 
and EC& values for TSH-increased inositol phosphate and the CAMP 
levels. 
The GH concentration in the cultured media of cells used for the 
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assays were determined by RIA. RNA from transfected Cos-7 cells was 
Northern blotted as previously described [2,4,6j using total RNA and 
a WT, full-length rat TSHR cDNA probe. 
2.4. Western blot 
Western blots of membrane proteins derived from an aliquot of 
Cos-7 cells transfected with WT or mutant receptor cDNA and used 
for the assays described above, were performed as described [8]. 
2.5. Statistics 
All values in Table 1 are presented as means f S.E.M. from multiple 
experiments as noted (Table 1). Student’s t-test was used for statistical 
analyses. Statistical differences in K,, and ECSo are calculated using 
log-transformed values. 
3. Results 
The 1 st cytoplasmic loops of the q-AR and &AR are 
identical in length to that of the TSHR, as they are in 
most receptors with 7 transmembrane domains [9]. Thr- 
447 in the TSHR is conserved in a,- and &ARs. We 
therefore created a series of mutants dividing the 1st 
cytoplasmic loop of the TSHR into 2 segments, residues 
441446 and 448450, and substituting counterpart resi- 
dues from the ARs (Fig. 1). These constructs are denoted 
as A or B for a,-AR and &AR substitutions, respec- 
tively, and by the initial residues substituted. For exam- 
ple, A441 substitutes a,-AR residues in the 441-446 po- 
sitions of TSHR. We additionally created a mutant with 
the same substitution in the 1st cytoplasmic loop as de- 
scribed by Chazenbalk et al. [lo]. This is termed R441 
and involves residues 441-450. Further, we created a 
Table 1 
Summary of mutant activities 
163 
EXTRACELLULAR 
\., \y;-:, 
WT TSHYKLTVPR 
A44 1 mtm4l-T V P R 
A448 TSHYKLT- 
B441 k-m_TVPR 
B449 TSH;KiTVm 
R44 1 m=JL aV P&j 
4478 TSHYKLLIVPR 
Fig. 1. Putative membrane topology of the transmembrane region of 
the rat TSH receptor (TSHR) and the amino acid sequence of its 1st 
cytoplasmic loop between residues 441 and 450. The boxed residues 
detail the sequence change in each TSHR mutant. The R441 mutant 
is the same as that previously described (MUTl-TSH-R in [lo]). 
Mutant pSG5 WT A441 B441 A448 B449 R441 4484 
TSH binding 
Ka @M) 
r 
213 + 23 17 zk 5** 9 f 3** 35 f 9** 106 f 31 10+3** ND’ 
%B,, (/wT) 100 7 f 3** 6 + 2** 7 f 1** 33 + 2** 6+1** ND 
CAMP increase 
EG, (PM) - 125 f 18 150 f 82 343 f 167 343 f 271 275 IL 141 181 + 90 NR”’ 
% Basal (/pSGS) 100 294 f 26 104 f 5** 91 + 14** 104 + 15** 121 + 6** 106 + 8** 102 + 7*+ 
Max Resp 
(/pSGS)+ _ 17.8 k 1.2 7.5 f 1.1* 3.7 + 0.3** 5.7 f 1.1** 10.7 + 0.3* 4.2 f 0.5** - 
Max resp 
(/basal)++ - 6.0 k 0.7 7.2 f 1.2 4.1 + 0.4* 5.5 f 1.1 8.8 f 0.3* 4.0 f 0.4* - 
IPn increase 
EG, (PM) - 571 XL 62 NR NR 2100 f 221* 1920 zk 165* NR NR 
% Basal (/pSGS) 100 96 + 2 95 + 1 101 + 3 99 f 3 98 f +l 102f4 95 f4 
Max Resp 
(IpSGS)’ _ 3.3 * 0.2 - 1.1 + 0.1** 1.3 k 0.1** - - 
Number of 
Experiments 9 9 3 3 3 3 3 3 
Values are expressed as means f S.E.M. of all experiments whose numbers are shown in the bottom line. 
wet detectable. 
##Non-responsive. 
**Statistically significant difference from WT (P c 0.01). 
*Statistically significant difference from WT (P C 0.05). 
‘Maximal response compared with basal of pSG5 transfectant (-fold). 
+‘Maximal response compared with basal of each mutant transfectant (-fold). 
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Fig. 2. Western blot of TSHR forms in membranes from Cos-7 cells 
transfected with 25 pug wild-type and mutant plasmid or the pSG5 
vector. 
point mutation at the conserved Thr-447 which is re- 
placed by Glu and termed 4474. The same designation 
is used to describe the mutant cDNA itself and the Cos-7 
cells transfected with the mutant cDNA. 
To accurately compare functional activities among 
transfectants, cells were transfected by electroporation in 
batches, and aliquots from one transfectant were used 
for GH measurement, Northern blots, Western blots, 
TSH binding and cAMP/inositol phosphate assays si- 
multaneously. Transfection efficiency, determined by co- 
transfecting 0.1 ,ug pSVGH and measuring the GH con- 
centrations in the culture media, was always within + 
15% of the mean. The mRNA in Cos-7 cells transfected 
with the mutants, estimated by Northern analysis of the 
total RNA, was identical in size and similar in amount 
(within f 20% of the mean) to that from cells transfected 
with full-length WT TSHR cDNA. All the mutants ex- 
hibited the same pattern and a similar amount of TSHR 
forms on Western blots of membrane preparations from 
the cells (Fig. 2). Thus, similar amounts of the three 
major TSHR forms, 230,180 and 95 kDa, were identified 
in three independent experiments using different batches 
of transfected cells. 
Ten ,uM ATP increased inositol phosphate levels 
3.7 + O.Cfold (mean f S.E.M.) in Cos-7 cells transfected 
with WT. Every mutant transfectant, exhibited essen- 
tially the same response to ATP (data not shown), indi- 
cating the abnormal inositol phosphate response to TSH 
or Graves’ IgG is TSHR specific. 
3.1. Functional activities of mutant receptors 
As shown in Fig. 3A and Table 1, A441 and B441 
exhibited a markedly increased binding affiity to TSH 
compared with WT. There was, however, a similar de- 
crease in B,,. The ECso for TSH in CAMP assays was 
not statistically different from that of WT. However, the 
maximal response relative to the level in pSG5 control 
transfectants was markedly decreased because the basal 
CAMP levels of these mutant transfectants were de- 
creased to the pSG5 level (Fig. 3B). Thus, WT increased 
the basal CAMP level compared with the pSG5 control 
transfectant as previously described [2]. The maximal 
response compared with the basal levels of the same 
transfectant in the absence of TSH, was slightly but sig- 
nificantly decreased in B441 (Table 1). In contrast, that 
was rather increased in A441. On the other hand, the 
increase in inositol phosphate levels induced by TSH was 
completely abolished in both A441 and B441. 
Mutants involving the carboxyl-terminal of the 1st 
cytoplasmic loop, A448 and B449, which replace only 3 
or 2 amino acids, respectively, also had marked effects 
on functional activities (Fig. 4 and Table 1). Both exhib- 
ited a significant decrease in TSH binding B_ and the 
affinity of A448 was significantly increased. The ECso in 
the TSH-CAMP response was not significantly different 
from the WT and the basal CAMP levels were markedly 
decreased, like those of A441 and B441. The maximal 
responses were also significantly decreased compared 
with WT when expressed relative to the pSG5 control 
transfectant level. The maximal response relative to the 
Fig. 3. Displacement of [“‘IjTSH binding by unlabeled TSH (A) and the ability of TSH to increase CAMP (B) and inositol phosphate formation 
(C) in Cos-7 cells transfected with wild-type (WT) and mutants involving the 1st cytoplasmic loop (A441, B441 and R441) (Fig. 1). The data in A 
are from a single experiment performed in duplicate. Essentially identical results were obtained in at least 3 separate xperiments. The & and B,, 
values determined by the program LIGAND [7j are noted in Table 1 and are the means (k S.E.M.) of all experiments. In B and C, each point is 
the mean k S.E.M. of all experiments, the number of which is noted in Table 1. In each case, data are from cells transfected with 25 pg cDNA, including 
cells with the pSG5 vector alone. TSH had no effect on CAMP or inositol phosphate formation in control cells transfected with pSG5. 
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Fig. 4. Displacement of [‘251]TSH binding by unlabeled TSH (A) and the ability of TSH to increase CAMP (B) and inositol phosphate formation 
(C) in Cos-7 cells transfected with WT and mutants involving the 1st cytoplasmic loop (A448, B449 and 4474) (Fig. 1). The conditions and expression 
of the data are exactly the same as those in Fig. 3. 
basal level without TSH in its own transfectant was actu- 
ally better in B449. In TSH-inositol phosphate assays, 
both mutants showed markedly decreased responses in 
terms of both EC,,, and maximal responses but they were 
still detectable, unlike A441 and B441. The only differ- 
ence between A448 and B449 is residue 448. Val-448 is 
replaced by Pro in A448. This might be attributed to a 
more profound loss in B_ and the maximal responses 
of cAMP/inositol phosphates to TSH in A448 by com- 
parison with B449. 
Chazenbalk et al. [lo] have reported that a non-homol- 
ogous substitution mutant involving the 1st cytoplasmic 
loop lost the CAMP response to TSH completely when 
transfected into Chinese hamster ovary cells. They con- 
cluded that the 1st cytoplasmic loop of the TSHR was 
also important for G, activation. Because there was no 
AR substitution mutant involving the 1st cytoplasmic 
loop that had lost the agonist-induced CAMP response, 
we created a mutant identical to that described by them 
[lo] and tested it under the same conditions as the AR 
substitution mutants. As shown in Fig. 3A and Table 1, 
R441 exhibited higher affinity and lower TSH binding 
Table 2 
CAMP and inositol phospate levels stimulated by Graves’ IgG’ 
&ax compared with WT. Although the maximal re- 
sponse relative to both the pSG5 control level and the 
basal level in the same transfectant in the absence of TSH 
were significantly lower than those of WI, the ECso in 
the TSH-CAMP response was not significantly different 
from that of WI (Fig. 3B and Table 1). The inositol 
phosphate response induced by TSH was completely 
abolished like that of A441 and B441 (Fig. 3C). 
Thr-447 is conserved among most receptors with 7 
transmembrane domains [9]. To evaluate its importance, 
we created a point mutation at this residue replacing it 
with Gln. Unexpectedly, this mutant neither bound TSH 
nor gave a cAMP/inositol phosphate response to TSH 
(Fig. 4 and Table 1) or Graves’ IgGs (Table 2), providing 
no informative evidence. This mutant has the smallest 
change in amino acid sequence among all the mutants 
created in this series. R441 also have Thr-447 replaced 
with Ala, but did not completely abolish TSH binding or 
signal transduction activities. 
As shown in Table 2, Graves’ IgG, which was used in 
our previous studies [2,4,6] stimulated the CAMP re- 
sponse in all the transfectants except 4474. The CAMP 
Mutant pSG5 WT A441 B441 A448 B449 R441 447Q 
CAMP (IpSGS)+ 
IgG’ 0.5 mg/ml 
5.0 mg/ml 
CAMP (lnormal IgG)‘+ 
IgG’ 0.5 mg/ml 
5.0 mg/ml 
IPn (IpSGS) + 
IgG’ 0.5 mg/ml 
5.0 mg/ml 
1.0 9.7 3.1 1.6 2.1 3.0 1.9 1.0 
1.0 14.0 5.1 2.2 3.1 5.9 2.8 1.0 
1.0 3.3 3.3 1.8 2.0 2.5 1.8 1.0 
1.0 4.8 4.9 2.4 3.0 4.9 2.6 1.0 
1.0 1.5 1.0 1.0 1.0 1.0 1.0 1.0 
1.0 2.5 1.0 1.0 1.1 1.1 1.0 1.0 
Values are expressed as means of 3 independent experiments performed in duplicate. Variances of values are within 20%. 
?kamlard Graves’s IgG, used in previous reports [2,4,6]. 
‘-Fold increase from basal activity in control pSG5 transfectant. 
++Fold increase from basal activity with 5.0 mg/ml normal IgG in each transfectant. 
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responses induced by Graves’ IgG in the mutants when 
compared with the pSG5 control transfectant level were 
markedly lower than those of WT because only WT 
increased the basal CAMP level. However, when com- 
pared with the basal level of each transfectant in the 
absence of TSH, A441 and B449 responded to Graves’ 
IgG similarly to WT. B441 and R441 responded poorly 
as was the case with maximal response to TSH. In con- 
trast, Graves’ IgG failed to increase inositol phosphates 
in any of the mutant transfectants. Generally, the CAMP 
and inositol phosphate responses induced by Graves’ 
IgG approximated the responses by TSH. 
4. Discussion 
All the AR substitutions and R441 involving the 1st 
cytoplasmic loop reasonably retained the agonist-in- 
duced CAMP response but decreased the basal CAMP 
level and almost completely lost the inositol phosphate 
response. They (except B449) had a markedly decreased 
TSH binding B,, and significantly increased binding 
affinity despite of a similar amount of the completely 
processed 95 kDa TSHR form on Western blots. 
These results lead to the conclusion that the entire 
portion of the first cytoplasmic loop of the TSHR is 
important for agonist-induced PIP2 signaling and the 
basal CAMP level, but that it is not crucial for the ag- 
onist-induced CAMP response. Furthermore, the present 
results together with those of other mutants involving the 
cytoplasmic loops of the TSHR such as mutations of 
Ala-623 in the 3rd cytoplasmic loop [2] suggest hat mu- 
tants which couple with G, but not with G, are shifted 
to a direction to higher affinity and lower capacity. In 
contrast, B525 [6] which involves the 2nd loop and cou- 
ples only with G,, shifts the equilibrium in the other 
direction, lower alEnity and higher capacity. 
The evidence obtained in these studies seem to be ap- 
plicable to gonadotropin receptors which are quite ho- 
mologous to TSHR in their transmembrane r gion, espe- 
cially in the first cytoplasmic loop. The differences in the 
1st loop among them are as follows. In the FSHR, the 
counterpart residue of His-443 in the TSHR is replaced 
by Gln [l 11. In the rat, human and mouse LI-KGR, it 
is replaced by Arg, but in the porcine LH/CGR it re- 
mains His [12]. Thr-447 is replaced by Asn in human 
TSHR [13] but conserved among all other glycoprotein 
hormone receptors thus far sequenced [I l-151. This and 
the results of 4474 might indicate the importance of 
Thr-447 in the functional expression of the receptor, such 
as proper protein folding. 
Finally, the data obtained from all substitution mu- 
tants involving one of the three cytoplasmic loops of the 
TSHR ([2,4,6] and present report) showed that: (i) the 
middle portion of the 2nd cytoplasmic loop of the TSHR 
is crucial for agonist-induced CAMP response; (ii) widely 
distributed portions of the three loops, namely the entire 
portion of the 1st cytoplasmic loop, the amino-terminal 
and middle portions of the 2nd cytoplasmic loop, and 
amino- and carboxyl-terminals of the 3rd cytoplasmic 
loop, are important for PIP, signaling; (iii) those por- 
tions are also important for increasing basal CAMP level; 
and (iv) the middle portion of the 3rd cytoplasmic loop 
is important for preventing the TSHR from activating 
signal transduction in the absence of agonist. 
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